Children with psoriasis infected by SARS-CoV-2

ABSTRACT

Objectives: To evaluate the impact of SARS-CoV-2 on psoriasis in children during and after SARS CoV- 2 infection. Method: We performed a retrospective study on children hospitalised with COVID-19 infection and diagnosed previously with severe psoriasis. Results: Case 1 A 16-year old boy, diagnosed with plaque psoriasis at the age of 10, was hospitalised 10 days for COVID-19 (confirmed by PCR) with fever, cough, headache. Before admission to the hospital for COVID-19 infection psoriasis was treated with phototherapy. During hospitalisation psoriasis remained the same and no Long-COVID was noted. Case 2 A 17-year-old boy diagnosed with plaque psoriasis at the age of 13 was hospitalised 12 days for COVID-19 (confirmed by PCR) with fever, cough, headache. Before admission to the hospital for COVID-19 infection psoriasis was treated with MTX. During hospitalisation psoriasis remained the same and no Long-COVID was noted. Case 3 A 16-year-old girl, diagnosed with plaque psoriasis at the age of 12, was hospitalised 12 days for COVID-19 (confirmed by PCR) with fever, cough, headache. Before admission to the hospital for COVID-19 infection psoriasis was treated with MTX. During hospitalisation psoriasis remained the same and no Long-COVID was noted. Discussion: No impact of SARS Cov2 infection was noted on evolution of children diagnosed and treated previously for severe psoriasis.